- call +1-201-465-4211
- email sales@mrinsights.biz
Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment.
Scope of the Report:
This report studies the Companion Diagnostic Technologies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Companion Diagnostic Technologies market by product type and applications/end industries.
Companion diagnostics is segmented on the basis of its use for indications such as oncology, cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology is the highest revenue generating segment, as majority of the companion diagnostics have been developed for detection of various cancer biomarkers. The key driver for this market is an increase in research and development of targeted drugs, which require a corresponding companion diagnostic.
The global Companion Diagnostic Technologies market is valued at 1960 million USD in 2017 and is expected to reach 5400 million USD by the end of 2023, growing at a CAGR of 18.3% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Companion Diagnostic Technologies.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories, Inc.
Ventana Medical Systems
bioMerieux
Myriad Genetics, Inc.
Resonance Health Ltd.
Leica Microsystems
Life Technologies
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Immunohistochemistry
Molecular Diagnostics
Market Segment by Applications, can be divided into
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Companion Diagnostic Technologies Market Overview
1.1 Product Overview and Scope of Companion Diagnostic Technologies
1.2 Classification of Companion Diagnostic Technologies by Types
1.2.1 Global Companion Diagnostic Technologies Revenue Comparison by Types (2017-2023)
1.2.2 Global Companion Diagnostic Technologies Revenue Market Share by Types in 2017
1.2.3 Immunohistochemistry
1.2.4 Molecular Diagnostics
1.3 Global Companion Diagnostic Technologies Market by Application
1.3.1 Global Companion Diagnostic Technologies Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Auto immune & Inflammation
1.3.6 Virology
1.3.7 Others
1.4 Global Companion Diagnostic Technologies Market by Regions
1.4.1 Global Companion Diagnostic Technologies Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Companion Diagnostic Technologies Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Companion Diagnostic Technologies Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Diagnostic Technologies Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Companion Diagnostic Technologies Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Diagnostic Technologies Status and Prospect (2013-2023)
1.5 Global Market Size of Companion Diagnostic Technologies (2013-2023)
2 Manufacturers Profiles
2.1 Dako (Agilent Technologies)
2.1.1 Business Overview
2.1.2 Companion Diagnostic Technologies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2016-2017)
2.2 Qiagen
2.2.1 Business Overview
2.2.2 Companion Diagnostic Technologies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Qiagen Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche
2.3.1 Business Overview
2.3.2 Companion Diagnostic Technologies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott Laboratories, Inc.
2.4.1 Business Overview
2.4.2 Companion Diagnostic Technologies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Laboratories, Inc. Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2016-2017)
2.5 Ventana Medical Systems
2.5.1 Business Overview
2.5.2 Companion Diagnostic Technologies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Ventana Medical Systems Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2016-2017)
2.6 bioMerieux
2.6.1 Business Overview
2.6.2 Companion Diagnostic Technologies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 bioMerieux Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2016-2017)
2.7 Myriad Genetics, Inc.
2.7.1 Business Overview
2.7.2 Companion Diagnostic Technologies Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Myriad Genetics, Inc. Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2016-2017)
2.8 Resonance Health Ltd.
2.8.1 Business Overview
2.8.2 Companion Diagnostic Technologies Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2016-2017)
2.9 Leica Microsystems
2.9.1 Business Overview
2.9.2 Companion Diagnostic Technologies Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Leica Microsystems Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2016-2017)
2.10 Life Technologies
2.10.1 Business Overview
2.10.2 Companion Diagnostic Technologies Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Life Technologies Companion Diagnostic Technologies Revenue, Gross Margin and Market Share (2016-2017)
3 Global Companion Diagnostic Technologies Market Competition, by Players
3.1 Global Companion Diagnostic Technologies Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Companion Diagnostic Technologies Players Market Share
3.2.2 Top 10 Companion Diagnostic Technologies Players Market Share
3.3 Market Competition Trend
4 Global Companion Diagnostic Technologies Market Size by Regions
4.1 Global Companion Diagnostic Technologies Revenue and Market Share by Regions
4.2 North America Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
4.3 Europe Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
4.5 South America Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
5 North America Companion Diagnostic Technologies Revenue by Countries
5.1 North America Companion Diagnostic Technologies Revenue by Countries (2013-2018)
5.2 USA Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
5.3 Canada Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
5.4 Mexico Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
6 Europe Companion Diagnostic Technologies Revenue by Countries
6.1 Europe Companion Diagnostic Technologies Revenue by Countries (2013-2018)
6.2 Germany Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
6.3 UK Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
6.4 France Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
6.5 Russia Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
6.6 Italy Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Companion Diagnostic Technologies Revenue by Countries
7.1 Asia-Pacific Companion Diagnostic Technologies Revenue by Countries (2013-2018)
7.2 China Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
7.3 Japan Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
7.4 Korea Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
7.5 India Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
8 South America Companion Diagnostic Technologies Revenue by Countries
8.1 South America Companion Diagnostic Technologies Revenue by Countries (2013-2018)
8.2 Brazil Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
8.3 Argentina Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
8.4 Colombia Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Companion Diagnostic Technologies by Countries
9.1 Middle East and Africa Companion Diagnostic Technologies Revenue by Countries (2013-2018)
9.2 Saudi Arabia Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
9.3 UAE Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
9.4 Egypt Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
9.5 Nigeria Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
9.6 South Africa Companion Diagnostic Technologies Revenue and Growth Rate (2013-2018)
10 Global Companion Diagnostic Technologies Market Segment by Type
10.1 Global Companion Diagnostic Technologies Revenue and Market Share by Type (2013-2018)
10.2 Global Companion Diagnostic Technologies Market Forecast by Type (2018-2023)
10.3 Immunohistochemistry Revenue Growth Rate (2013-2023)
10.4 Molecular Diagnostics Revenue Growth Rate (2013-2023)
11 Global Companion Diagnostic Technologies Market Segment by Application
11.1 Global Companion Diagnostic Technologies Revenue Market Share by Application (2013-2018)
11.2 Companion Diagnostic Technologies Market Forecast by Application (2018-2023)
11.3 Oncology Revenue Growth (2013-2018)
11.4 Cardiovascular Revenue Growth (2013-2018)
11.5 Central Nervous System Revenue Growth (2013-2018)
11.6 Auto immune & Inflammation Revenue Growth (2013-2018)
11.7 Virology Revenue Growth (2013-2018)
11.8 Others Revenue Growth (2013-2018)
12 Global Companion Diagnostic Technologies Market Size Forecast (2018-2023)
12.1 Global Companion Diagnostic Technologies Market Size Forecast (2018-2023)
12.2 Global Companion Diagnostic Technologies Market Forecast by Regions (2018-2023)
12.3 North America Companion Diagnostic Technologies Revenue Market Forecast (2018-2023)
12.4 Europe Companion Diagnostic Technologies Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Companion Diagnostic Technologies Revenue Market Forecast (2018-2023)
12.6 South America Companion Diagnostic Technologies Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Companion Diagnostic Technologies Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Companion Diagnostic Technologies Picture
Table Product Specifications of Companion Diagnostic Technologies
Table Global Companion Diagnostic Technologies and Revenu
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
